Leila Sisic

Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?

Susanne Blank, Thomas Schmidt, Patrick Heger et al. · Gastric Cancer · 2017 · 100 citations

Surgical Oncology, Aeg Ii, Surgical Strategies +10

Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial

Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Andreas G. Niethammer et al. · OncoImmunology · 2015 · 72 citations · Full text

Prognostic significance of microsatellite‐instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy

Georg Martin Haag, Elena Czink, Aysel Ahadova et al. · International Journal of Cancer · 2018 · 57 citations · Full text

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +14

A reliable risk score for stage IV esophagogastric cancer

Susanne Blank, Florian Lordick, Martin Dobritz et al. · European Journal of Surgical Oncology · 2013 · 56 citations

Epidemiology, Esophagus, Esophageal Cancer +6

Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer

Susanne Blank, Henrik Nienhüser, Lena Dreikhausen et al. · Oncotarget · 2017 · 56 citations · Full text